Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Cancer image

Fixing what’s broken: why companies must prioritise innovation in drug development

March 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …
Feature
franklin_berger

ESSA Pharma appoints independent director

March 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger

US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …
Appointment
Novartis image

Novartis secures first US biosimilar product

March 6, 2015 Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …
News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015 Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …
News
scott_byrd

Acacia Pharma appoints two directors to board

March 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acacia pharma, christine soden, scott byrd

UK pharma firm Acacia Pharma that develops drugs for supportive care has confirmed Scott Byrd and Christine Soden have joined …
Appointment
BMS image

BMS’ Opdivo wins US lung cancer race

March 5, 2015 Research and Development, Sales and Marketing BMS, Prostvac, biosciences, flexus, lung cancer, oncology, opdivo

The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer …
News
rafael_amado

Adaptimmune makes executive hires from GSK

March 5, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Adrian Rawcliffe, Rafael Amado

UK and US clinical-stage biotech firm Adaptimmune has increased its senior team with the appointment of Dr Rafael Amado as …
Appointment

EU widens indications for Pfizer vaccine

March 4, 2015 Research and Development, Sales and Marketing EC, EMA, Pfizer, pneumococcal polysaccharide conjugate vaccine, prevenar

Pfizer has gained approval from the European Commission which has signed off on an EMA decision to recommend Prevenar 13 …
News
Christophe Weber image

New chief executive for Takeda

March 4, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actos, Millennium, Nycomed, Takeda, Yasuchika Hasegawa, christophe weber

Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …
News
richard_douglas

Finance director general for Department of Health retiring

March 4, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, DoH, director general, finance, richard douglas

The Department of Health’s director general for finance and the NHS Richard Douglas is to retire at the end of …
Appointment
AZ image

AstraZeneca completes respiratory deal with Actavis

March 3, 2015 Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast

AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …
News
beth_ratliff

Premise Health senior joins Nashville Health Care Council

March 3, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing nashville health care council, premise health

US worksite health and patient engagement firm Premise Health has announced that its senior VP Beth Ratliff has been selected …
Appointment
Ebola image

ZMapp trials start in Liberia

March 2, 2015 Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp

Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …
News
Novartis image

Three drugs put forward for EMA authorisation

March 2, 2015 Research and Development, Sales and Marketing Amgen, EMA, FDA, Novartis, Otsuka, jinarc, ristempa, zykadia

Novartis’ lung cancer drug Zykadia has been recommended for EU approval in patients previously treated with Pfizer’s Xalkori – the …
News
kate_black_23andme

23andMe appoints privacy officer

March 2, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, kate black

US genetics testing firm 23andMe has appointed Kate Black as its privacy officer and corporate counsel.
Appointment
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026